Price : 2,750
PT Enseval Putera Megatrading Tbk., together with its subsidiaries, engages in the distribution and supply of pharmaceutical products in Indonesia. The company operates through three segments: Pharmaceutical, Consumer Products, and Others. It also trades in medical and laboratory equipment and supplies; operates health care clinics; and offers dental and other equipment, as well as calibration services. In addition, the company engages in the trading of raw materials for pharmaceutical products; consumable products for hemodialysis therapy; and food and beverages. Further, it offers warehousing services, including chiller, cool, and ambient rooms, as well as container chiller. The company was formerly known as PT Arya Gupta Cempaka and changed its name to PT Enseval Putera Megatrading Tbk. in August 1993. The company was incorporated in 1973 and is headquartered in East Jakarta, Indonesia. PT Enseval Putera Megatrading Tbk. is a subsidiary of PT Kalbe Farma Tbk.
Nama Perusahaan | Enseval Putera Megatrading Tbk. |
Sektor | Barang Konsumen Primer |
Sub Sektor | Perdagangan Ritel Barang Primer |
Industri | Perdagangan Ritel Barang Primer |
Sub Industri | Ritel & Distributor Obat-obatan |
Jumlah saham beredar | 2,708,640,000 lembar |
TTM | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Pendapatan | 27,688,908,214,825 | 25,673,756,765,637 | 22,545,419,368,639 | 22,226,912,485,948 | 20,604,487,293,751 |
Beban Pendapatan | 24,761,099,105,739 | 22,909,420,077,066 | 20,126,674,426,173 | 19,813,964,935,955 | 18,242,996,240,334 |
Gross Profit | 0 | 2,764,336,688,571 | 2,418,744,942,466 | 2,412,947,549,993 | 2,361,491,053,417 |
Pretax Income | 1,090,275,548,124 | 1,091,263,311,440 | 882,739,797,483 | 813,103,428,517 | 879,481,177,101 |
Laba Bersih | 843,773,483,563 | 847,881,142,916 | 680,597,939,678 | 580,629,918,596 | 653,064,164,661 |
2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|
Total Aset | 1,678,097,734,000,000 | 1,610,065,344,000,000 | 1,416,758,840,000,000 | 1,296,898,292,000,000 |
Aset Lancar | 239,501,504,000,000 | 248,039,092,000,000 | 283,532,132,000,000 | 248,321,832,000,000 |
Other Current Assets | 72,424,801,000,000 | 64,926,607,000,000 | 85,661,529,000,000 | 86,863,588,000,000 |
Total Liabilities | 1,386,310,930,000,000 | 1,380,598,462,000,000 | 1,207,974,504,000,000 | 1,111,622,961,000,000 |
Liabilitas Lancar | 1,269,940,609,000,000 | 1,236,896,249,000,000 | 1,099,893,475,000,000 | 1,011,268,460,000,000 |
Other Liabilitas Lancar | 32,750,238,000,000 | 24,430,292,000,000 | 17,230,709,000,000 | 20,256,111,000,000 |
Total Ekuitas | 291,786,804,000,000 | 229,466,882,000,000 | 208,784,336,000,000 | 185,275,331,000,000 |
Item | Highlight | Score |
---|---|---|
Tier Saham | Saham Tier 1 (Market Cap >40T) | 1 |
Net Profit | Net profit selama 5th | 1 |
Return On Equity | Rasio profitabilitas kurang baik | 0 |
Rasio Hutang | Rasio hutang kurang baik | 1 |
Current Ratio | Aset Liabilitas ancar | 1 |
Price to Book Value | 0.35 : undervalue | 1 |
Rerata EPS 3 tahun | Net profit selama 5th | 1 |
Harga Wajar | Perkiraan Harga Wajar (Graham Number) | 1 |
Item | Highlight | Score |
---|---|---|
Tier Saham | Saham Tier 1 (Market Cap >40T) | 1 |
Net Profit | Net profit selama 5th | 1 |
Return On Equity | Rasio profitabilitas kurang baik | 0 |
Rasio Hutang | Rasio hutang kurang baik | 1 |
Current Ratio | Aset Liabilitas ancar | 1 |
Price to Book Value | 0.35 : undervalue | 1 |
Rerata EPS 3 tahun | Net profit selama 5th | 1 |
Harga Wajar | Perkiraan Harga Wajar (Graham Number) | 1 |